| Dr Sharon Kaye Davis, MD | |
|
101 E Brunson St Ste 300, Enterprise, AL 36330-2500 | |
| (334) 393-3212 | |
| Not Available |
| Full Name | Dr Sharon Kaye Davis |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 39 Years |
| Location | 101 E Brunson St Ste 300, Enterprise, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962478198 | NPI | - | NPPES |
| ME51503 | Other | FL | STATE FL DEPT HEALTH |
| 375307700 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical Center Enterprise | Enterprise, AL | Hospital |
| Medical Center Barbour | Eufaula, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Enterprise Clinic Llc | 1456488667 | 5 |
News Archive
Today, during the 39th Annual Meeting of the American Association for Dental Research, convening at the Walter E. Washington Convention Center in Washington, DC, lead researcher O.A. Gonzalez (University of Kentucky, Lexington) will present a poster of a study titled "TLR2 and TLR9 Activation by Periodontal Pathogens induce HIV-1 Reactivation."
Guideline-recommended diagnostic tests for hypertension complications, such as echocardiograms and renal ultrasonography, are being poorly used in adolescents, a study suggests.
Vanda Pharmaceuticals Inc. presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies in Baltimore, from its SET (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of the Efficacy and Safety of Tasimelteon to treat Non-24-Hour Disorder) Phase III studies of tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24) in totally blind individuals.
Nitrous oxide, or laughing gas, has shown early promise as a potential treatment for severe depression in patients whose symptoms don't respond to standard therapies. The pilot study, at Washington University School of Medicine in St. Louis, is believed to be the first research in which patients with depression were given laughing gas.
Prenatal screening for Down syndrome (DS) is still in need of improvement. Perinatal medicine experts have worked hard to find new biomarkers for screening of DS. Dr. Shi he Shao and his co-investigators, from Jiangsu University and Changzhou Woman and Children Health Hospital, report in the May 2012 issue of Experimental Biology and Medicine that they have successfully identified twenty-nine differentially expressed proteins in maternal serum from pregnancies carrying DS fetuses with proteomic approaches.
› Verified 9 days ago
| Entity Name | Houston County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619026606 PECOS PAC ID: 9436062296 Enrollment ID: O20040219000209 |
News Archive
Today, during the 39th Annual Meeting of the American Association for Dental Research, convening at the Walter E. Washington Convention Center in Washington, DC, lead researcher O.A. Gonzalez (University of Kentucky, Lexington) will present a poster of a study titled "TLR2 and TLR9 Activation by Periodontal Pathogens induce HIV-1 Reactivation."
Guideline-recommended diagnostic tests for hypertension complications, such as echocardiograms and renal ultrasonography, are being poorly used in adolescents, a study suggests.
Vanda Pharmaceuticals Inc. presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies in Baltimore, from its SET (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of the Efficacy and Safety of Tasimelteon to treat Non-24-Hour Disorder) Phase III studies of tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24) in totally blind individuals.
Nitrous oxide, or laughing gas, has shown early promise as a potential treatment for severe depression in patients whose symptoms don't respond to standard therapies. The pilot study, at Washington University School of Medicine in St. Louis, is believed to be the first research in which patients with depression were given laughing gas.
Prenatal screening for Down syndrome (DS) is still in need of improvement. Perinatal medicine experts have worked hard to find new biomarkers for screening of DS. Dr. Shi he Shao and his co-investigators, from Jiangsu University and Changzhou Woman and Children Health Hospital, report in the May 2012 issue of Experimental Biology and Medicine that they have successfully identified twenty-nine differentially expressed proteins in maternal serum from pregnancies carrying DS fetuses with proteomic approaches.
› Verified 9 days ago
| Entity Name | Enterprise Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639491616 PECOS PAC ID: 1456488667 Enrollment ID: O20100420000715 |
News Archive
Today, during the 39th Annual Meeting of the American Association for Dental Research, convening at the Walter E. Washington Convention Center in Washington, DC, lead researcher O.A. Gonzalez (University of Kentucky, Lexington) will present a poster of a study titled "TLR2 and TLR9 Activation by Periodontal Pathogens induce HIV-1 Reactivation."
Guideline-recommended diagnostic tests for hypertension complications, such as echocardiograms and renal ultrasonography, are being poorly used in adolescents, a study suggests.
Vanda Pharmaceuticals Inc. presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies in Baltimore, from its SET (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of the Efficacy and Safety of Tasimelteon to treat Non-24-Hour Disorder) Phase III studies of tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24) in totally blind individuals.
Nitrous oxide, or laughing gas, has shown early promise as a potential treatment for severe depression in patients whose symptoms don't respond to standard therapies. The pilot study, at Washington University School of Medicine in St. Louis, is believed to be the first research in which patients with depression were given laughing gas.
Prenatal screening for Down syndrome (DS) is still in need of improvement. Perinatal medicine experts have worked hard to find new biomarkers for screening of DS. Dr. Shi he Shao and his co-investigators, from Jiangsu University and Changzhou Woman and Children Health Hospital, report in the May 2012 issue of Experimental Biology and Medicine that they have successfully identified twenty-nine differentially expressed proteins in maternal serum from pregnancies carrying DS fetuses with proteomic approaches.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sharon Kaye Davis, MD 101 E Brunson St Ste 300, Enterprise, AL 36330-2500 Ph: (334) 393-3212 | Dr Sharon Kaye Davis, MD 101 E Brunson St Ste 300, Enterprise, AL 36330-2500 Ph: (334) 393-3212 |
News Archive
Today, during the 39th Annual Meeting of the American Association for Dental Research, convening at the Walter E. Washington Convention Center in Washington, DC, lead researcher O.A. Gonzalez (University of Kentucky, Lexington) will present a poster of a study titled "TLR2 and TLR9 Activation by Periodontal Pathogens induce HIV-1 Reactivation."
Guideline-recommended diagnostic tests for hypertension complications, such as echocardiograms and renal ultrasonography, are being poorly used in adolescents, a study suggests.
Vanda Pharmaceuticals Inc. presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies in Baltimore, from its SET (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of the Efficacy and Safety of Tasimelteon to treat Non-24-Hour Disorder) Phase III studies of tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24) in totally blind individuals.
Nitrous oxide, or laughing gas, has shown early promise as a potential treatment for severe depression in patients whose symptoms don't respond to standard therapies. The pilot study, at Washington University School of Medicine in St. Louis, is believed to be the first research in which patients with depression were given laughing gas.
Prenatal screening for Down syndrome (DS) is still in need of improvement. Perinatal medicine experts have worked hard to find new biomarkers for screening of DS. Dr. Shi he Shao and his co-investigators, from Jiangsu University and Changzhou Woman and Children Health Hospital, report in the May 2012 issue of Experimental Biology and Medicine that they have successfully identified twenty-nine differentially expressed proteins in maternal serum from pregnancies carrying DS fetuses with proteomic approaches.
› Verified 9 days ago
Mrs. Elisha M Collins, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 E Brunson St Ste 300, Enterprise, AL 36330 Phone: 334-393-3212 Fax: 614-656-3761 | |
Andrew A Duerr, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1008 Boll Weevil Cir, Suite D, Enterprise, AL 36330 Phone: 334-347-0639 Fax: 334-347-1021 | |
Mr. Samuel Fleming Sawyer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 E Brunson St, Suite 300, Enterprise, AL 36330 Phone: 334-393-3212 Fax: 334-393-4979 | |
William Kettunen, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 806 Glover Ave, Suite B, Enterprise, AL 36330 Phone: 334-489-4649 | |
Dr. Reza David Seirafi, MD FACS Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 E Brunson St Ste 300, Enterprise, AL 36330 Phone: 334-393-3212 Fax: 334-393-8747 | |
Dr. William Daniel Sawyer, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 101 E Brunson St, Ste 300, Enterprise, AL 36330 Phone: 334-393-3212 Fax: 334-393-4979 | |
Dr. Sherry Lynn Roach, MD Surgery Medicare: Medicare Enrolled Practice Location: 101 E Brunson St, Ste 300, Enterprise, AL 36330 Phone: 334-393-3212 Fax: 334-393-4979 |